June 27, 2022, 14:30
Paris
Scope and objective
The workshop, organized by TSE, brought together a group of researchers from different affiliations to present recent advances in healthcare innovation, regulation and organization and to foster discussion with policy and decision makers (see the program).
The organizing committee warmly thanks the 75 participants who attended the workshop in person, as well as the partners of the TSE Health Center for their support (LEEM, GIE Gers and bioMérieux).
Watch the replay of the workshop:
- Session 1 : Price regulation, innovation and access to innovative drugs
- Session 2 : Healthcare savings sources and better quality of care
Visit TSE Health Center web site for additional information on publications and forthcoming events.
Speakers
David Bardey (University of Los Andes, TSE)
Pierre Dubois (TSE)
Margareth Kyle (Mines Paris Tech)
Thierry Magnac (TSE)
Luca Maini (University of North Carolina, Chapel Hill
Carol Propper (Imperial College London)
Julian Reif (University of Illinois)
Ariel Stern (Harvard Business School)
Jean Tirole (TSE)
Organizing committee
Pierre Dubois (TSE), Jean Tirole (TSE).
Conference venue
Châteauform’ - Le 28 George V
28 avenue George V
75008 Paris
France
Contact
© iStock
List of communications
Pierre Dubois (Toulouse School of Economics), “Drug Shortages Determinants”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.
Thierry Magnac (Toulouse School of Economics), “Optimal Intertemporal Setting of Drug Expenses: Hepatitis C as a case study”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.
Luca Maini (University of North Carolina, Chapel Hill), “Reference Pricing in Europe and Beyond”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.
Carol Propper (Imperial College London), “Team Production in Healthcare”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.
Julian Reif (University of Illinois), “Health Risk and the Value of Life”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.
Ariel Stern (Harvard Business School), “Regulatory Incentives for Innovation: The FDA’s Breakthrough Therapy Designation”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.